Elevated HbA1c is associated with increased risk of incident dementia in primary care patients

Journal of Alzheimer's Disease

Volumn 44, Issue 4, 2015, Pages 1203-1212

  Ramirez, Alfredo ^a,b   Lange, Carolin ^c   Kaduszkiewicz, Hanna ^c   Weyerer, Siegfried ^d   Werle, Jochen ^d   Pentzek, Michael ^e   Fuchs, Angela ^e   Riedel Heller, Steffi G ^f   Luck, Tobias ^f   Mösch, Edelgard ^g   Bickel, Horst ^g   Wiese, Birgitt ^h   Prokein, Jana ^h   König, Hans Helmut ^c   Brettschneider, Christian ^c   Breteler, Monique M ^b   Maier, Wolfgang ^a,b  

^a UNIVERSITY OF BONN   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f UNIVERSITY OF LEIPZIG   (Germany)

^g TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^h HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Alzheimer's disease; diabetes mellitus; epidemiology; glycosylated hemoglobin; incident dementia

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; ARTICLE; DEMENTIA; FEMALE; HIGH RISK POPULATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; VERY ELDERLY; BLOOD; COMORBIDITY; DIABETES MELLITUS, TYPE 2; MENTAL HEALTH; METABOLISM; PRIMARY HEALTH CARE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

AGED; AGED, 80 AND OVER; COMORBIDITY; DEMENTIA; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MENTAL STATUS SCHEDULE; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84923270529     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-141521     Document Type: Article

References (47)

1. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurol 5, 64-74.
2. Strachan MW, Reynolds RM, Marioni RE, Price JF (2011) Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol 7, 108-114.
3. Hsu CC, Wahlqvist ML, Lee MS, Tsai HN (2011) Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimers Dis 24, 485-493.
4. Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, APOEgene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51, 1256-1262.
5. Bruce DG, Davis WA, Casey GP, Starkstein SE, Clarnette RM, Foster JK, Almeida OP, Davis TM (2008) Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 51, 241-248.
6. Nathan DM, Balkau B, Bonora E, Borch-Johnsen K, Buse JB, Colagiuri S, Davidson MB, DeFronzo R, Genuth S, Holman RR, Ji L, Kirkman S, Knowler WC, Schatz D, Shaw J, Sobngwi E, Steffes M, Vaccaro O, Wareham N, Zinman B, Kahn R (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32, 1327-1334.
7. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR (2012) Management of hyperglycemia in type 2 diabetes: A patient-centered approach: Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35, 1364-1379.
8. Fonseca V, Inzucchi SE, Ferrannini E (2009) Redefining the diagnosis of diabetes using glycated hemoglobin. Diabetes Care 32, 1344-1345.
9. (2013) American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 36 (Suppl 1), S11-S66.
10. Xu WL, von Strauss E, Qiu CX, Winblad B, Fratiglioni L (2009) Uncontrolled diabetes increases the risk of Alzheimer's disease: A population-based cohort study. Diabetologia 52, 1031-1039.
11. Gao L, Matthews FE, Sargeant LA, BrayneC (2008)Aninvestigation of the population impact of variation in HbA1c levels in older people in England and Wales: From a population based multi-centre longitudinal study. BMC Public Health 8, 54.
12. Yaffe K, Falvey C, Hamilton N, Schwartz AV, Simonsick EM, Satterfield S, Cauley JA, Rosano C, Launer LJ, Strotmeyer ES, Harris TB (2012) Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. Arch Neurol 69, 1170-1175.
13. Yaffe K, Blackwell T, Whitmer RA, Krueger K, Barrett Connor E (2006) Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. J Nutr Health Aging 10, 293-295.
14. Christman AL, Matsushita K, Gottesman RF, Mosley T, Alonso A, Coresh J, Hill-Briggs F, Sharrett AR, Selvin E (2011) Glycated haemoglobin and cognitive decline: The Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 54, 1645-1652.
15. Ravona-Springer R, Moshier E, Schmeidler J, Godbold J, Akrivos J, Rapp M, GrossmanHT, Wysocki M, Silverman JM, Haroutunian V, Beeri MS (2012) Changes in glycemic control are associated with changes in cognition in non-diabetic elderly. J Alzheimers Dis 30, 299-309.
16. Enzinger C, Fazekas F, Matthews PM, Ropele S, Schmidt H, Smith S, Schmidt R (2005) Risk factors for progression of brain atrophy in aging: Six-year follow-up of normal subjects. Neurology 64, 1704-1711.
17. Jessen F, Wiese B, Bickel H, Eifflander-Gorfer S, Fuchs A, Kaduszkiewicz H, Kohler M, Luck T, Mosch E, Pentzek M, Riedel-Heller SG, Wagner M, Weyerer S, Maier W, van den Bussche H (2011) Prediction of dementia in primary care patients. PLoS One 6, e16852.
18. Luck T, Riedel-Heller SG, Kaduszkiewicz H, Bickel H, Jessen F, Pentzek M, Wiese B, Koelsch H, van den Bussche H, Abholz HH, Moesch E, Gorfer S, Angermeyer MC, Maier W, Weyerer S (2007) Mild cognitive impairment in general practice: Age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement Geriatr Cogn Disord 24, 307-316.
19. Zaudig M, Mittelhammer J, Hiller W, Pauls A, Thora C, Morinigo A, MombourW (1991) SIDAM-A structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other aetiology according to ICD-10 and DSM-III-R. Psychol Med 21, 225-236.
20. Zaudig M, Hiller W. (1996) SIDAM-A structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct (or vascular) dementia and dementias of other aetiology according to DSM-III-R, DSM-IV, and ICD-10 (SIDAM-manual) [in German]. Bern, Germany, Huber.
21. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
22. Sheikh JI, Yesavage JA (1986) Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. Clin Gerontol 5, 165-173.
23. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34, 939-944.
24. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, HofmanAet al. (1993)Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260.
25. Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 139, 1136-1139.
26. Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114, 797-811.
27. Xu W, Qiu C, Winblad B, Fratiglioni L (2007) The effect of borderline diabetes on the risk of dementia and Alzheimer's disease. Diabetes 56, 211-216.
28. Crane PK, Walker R, Hubbard RA, Li G, Nathan DM, Zheng H, Haneuse S, Craft S, Montine TJ, Kahn SE, McCormick W, McCurry SM, Bowen JD, Larson EB (2013) Glucose levels and risk of dementia. N Engl J Med 369, 540-548.
29. Creavin ST, Gallacher J, Bayer A, Fish M, Ebrahim S, Ben-Shlomo Y (2012) Metabolic syndrome, diabetes, poor cognition, and dementia in the Caerphilly prospective study. J Alzheimers Dis 28, 931-939.
30. Raffaitin C, Gin H, Empana JP, Helmer C, Berr C, Tzourio C, Portet F, Dartigues JF, Alperovitch A, Barberger-Gateau P (2009) Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: The Three-City Study. Diabetes Care 32, 169-174.
31. Siervo M, Harrison SL, Jagger C, Robinson L, Stephan BC (2014) Metabolic syndrome and longitudinal changes in cognitive function: A systematic review and meta-analysis. J Alzheimers Dis 41, 151-161.
32. Solfrizzi V, Scafato E, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Vendemiale G, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Capurso A, Panza F, Italian. Longitudinal Study on Ageing Working G (2010) Metabolic syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Ageing. J Neurol Neurosurg Psychiatry 81, 433-440.
33. Solfrizzi V, Scafato E, Capurso C, D'Introno A, Colacicco AM, FrisardiV, Vendemiale G, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Capurso A, Panza F, Italian Longitudinal Study on Aging Working G (2011) Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Neurobiol Aging 32, 1932-1941.
34. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA (2007) Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 24, 185-192.
35. de la MonteSM (2012) Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res 9, 35-66.
36. De Felice FG, Ferreira ST (2014) Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes 63, 2262-2272.
37. Qiu WQ, Folstein MF (2006) Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: Review and hypothesis. Neurobiol Aging 27, 190-198.
38. Luitse MJ, Biessels GJ, Rutten GE, Kappelle LJ (2012) Diabetes, hyperglycaemia, and acute ischaemic stroke. Lancet Neurol 11, 261-271.
39. Buchman AS, Wilson RS, Bienias JL, Shah RC, Evans DA, Bennett DA (2005) Change in body mass index and risk of incident Alzheimer disease. Neurology 65, 892-897.
40. Fratiglioni L, Launer LJ, Andersen K, BretelerMM, Copeland JR, Dartigues JF, Lobo A, Martinez-Lage J, Soininen H, Hofman A (2000) Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54, S10-S15.
41. Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, van Belle G, Jolley L, Larson EB (2002) Dementia and Alzheimer disease incidence: A prospective cohort study. Arch Neurol 59, 1737-1746.
42. Exalto LG, Whitmer RA, Kappele LJ, Biessels GJ (2012) An update on type 2 diabetes, vascular dementia and Alzheimer's disease. Exp Gerontol 47, 858-864.
43. Berlie HD, Garwood CL (2010) Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly. Ann Pharmacother 44, 712-717.
44. Gerstein HC, Miller ME, Byington RP, GoffDC Jr, Bigger JT, Buse JB, CushmanWC, Genuth S, Ismail-Beigi F, GrimmRH, Probstfield JL, Simons-Morton DG, Friedewald WT (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358, 2545-2559.
45. Yaffe K, Falvey CM, Hamilton N, Harris TB, Simonsick EM, Strotmeyer ES, Shorr RI, Metti A, Schwartz AV (2013) Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med 173, 1300-1306.
46. Kodl CT, Seaquist ER (2008) Cognitive dysfunction and diabetes mellitus. Endocr Rev 29, 494-511.
47. Punthakee Z, Miller ME, Launer LJ, Williamson JD, Lazar RM, Cukierman-Yaffee T, Seaquist ER, Ismail-Beigi F, Sullivan MD, Lovato LC, Bergenstal RM, Gerstein HC (2012) Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: Post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care 35, 787-793.